Drugs / ChAd63 ME-TRAP
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT03084289 | Mar 2017 → Jul 2020 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1 | NCT01669512 | Aug 2012 → Dec 2014 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT05441410 | Jun 2025 → Jun 2026 overdue | malaria | University Hospital Tuebingen | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT03707353 | Oct 2018 → Jun 2019 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03947190 | Aug 2022 → Feb 2023 | Plasmodium falciparum malaria | University of Oxford | Terminated | No outcome recorded |
| Phase 2 | NCT01666925 | Mar → Aug 2012 | malaria | University of Oxford | Completed | No outcome recorded |
Also used as a comparator or background therapy in 8 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02083887 Comparator | Feb 2014 → Nov 2015 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/26 trials | ||||||
| Phase 1/2 | NCT02905019 Comparator | Aug 2016 → Dec 2017 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/2 | NCT02252640 Comparator | Jan → Oct 2015 | Plasmodium falciparum malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/2 | NCT01883609 Comparator | Sep 2013 → Aug 2014 | Plasmodium falciparum malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/2 | NCT01739036 Comparator | Jan → Oct 2013 | Plasmodium falciparum malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/2 | NCT01635647 Comparator | Nov 2012 → Aug 2014 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/2 | NCT01623557 Comparator | Apr → Nov 2012 | Plasmodium falciparum malaria | University of Oxford | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01658696 Comparator | Aug 2012 → Feb 2013 | malaria | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChAd63 ME-TRAP | “1 dose of ChAd63 ME-TRAP 5 x 10\^10 vp intramuscularly and 1 dose MVA ME-TRAP 2 x 10\^8 pfu intramuscularly 8 weeks later.” NCT01623557 ↗13“Mixture of ChAd63 CS 5 x 1010 vp and ChAd63 ME-TRAP 5 x 1010 vp. Intramuscular needle injection.” NCT01739036 ↗ “5x10\^10 vp ChAd63 ME-TRAP and 2x10\^8 pfu MVA ME-TRAP vaccines, 8 weeks apart” NCT03947190 ↗ “ChAd63 ME-TRAP 5 x 1010 vp on Day 0 and MVA ME-TRAP 2 x 108 pfu on Day 56” NCT01669512 ↗ |
| Modality | Vaccine | “the Candidate Malaria Vaccines ChAd63 ME-TRAP and MVA ME-TRAP” NCT01635647 ↗ |
| Route | Intramuscular | “1 dose of ChAd63 ME-TRAP 5 x 10\^10 vp intramuscularly” NCT01623557 ↗ |